A Risk-Benefit Assessment of HIV Protease Inhibitors
- 作者Dr Graeme J. Moyle, Brian G. Gazzard
- 卷第20卷
- 期第4期
- 文件大小230.90KB
- 发表时间1999-04
- DOI10.2165/00002018-199920040-00002
- 页码299-321
Topographical localization of motor endplates in cryosections of whole human musclesDr. Sten-Magnus Aquilonius; Dr. Håkan Askmark; Dr. Per-Göuran Gillberg; Dr. Sanjeev Nandedkar; Dr. Yngve Olsson; Dr. Erik Stårlberg · 1984
Botanical Nomenclature in Pharmacovigilance and a Recommendation for StandardisationDr Mohamed H. Farah, Sten Olsson, Jenny Bate, Marie Lindquist, Ralph Edwards, Monique S.J. Simmonds, Christine Leon, Hugo J. de Boer, Mats Thulin · 2006
Proteoglycan alterations during developing experimental osteoarthritis in a novel hip joint modelSven Inerot; Dr. Dick Heinegård; Sten-Erik Olsson; Hans Telhag; Lars Audell · 1991
An Analysis of Vigimed, a Global E-Mail System for the Exchange of Pharmacovigilance InformationKristina Johansson, Sten Olsson, Björn Hellman, Dr Ronald H. B. Meyboom · 2007
Organ-specific autoantigens induce transforming growth factor-β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravisDr. Joanne Link; Sten Fredrikson; Mats Söderström; Tomas Olsson; Bo Höjeberg; Åke Ljungdahl; Hans Link · 1994